Buscar resultados de ensayos clínicos
Anaplastic Ependymoma - 84 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Carboplatin and Bevacizumab for Recurrent Ependymoma Condición:
Fecha: 2011-02-11 Intervenciones:
|
Recruiting |
Nombre del estudio: Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine Condición:
|
Withdrawn |
Nombre del estudio: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors Condición:
|
Active, not recruiting |
Nombre del estudio: Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas Condición:
Fecha: 2011-11-17 Intervenciones: |
Completed |
Nombre del estudio: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 Condición:
|
Recruiting |
Nombre del estudio: Everolimus for Children With Recurrent or Progressive Ependymoma Condición: Recurrent Childhood Ependymoma Fecha: 2014-05-29 Intervenciones: Drug: Everolimus The recommended dose of Everolimus is 4.5 mg/m2/dose, once daily for up to 2 years, unt |
Terminated |
Nombre del estudio: Antineoplaston Therapy in Treating Patients With Ependymoma Condición: Ependymoma Fecha: 1999-11-01 Intervenciones: Drug: Antineoplaston therapy (Atengenal + Astugenal) Patients with an ependymoma will receive Antineopla |
Terminated |
Nombre del estudio: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma Condición:
|
Not yet recruiting |
Nombre del estudio: Phase II Pediatric Study With Dabrafenib in HGG Patients Condición:
|
Not yet recruiting |
Nombre del estudio: Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas Condición:
Intervenciones: Drug: AXL1717 IGF-1 receptor inhibitor Other Name: p |